Scholars Central

Review articlePublished 2021

Crosstalk Between Sirt1 Activators And Nf-?b Axis As A Therapeutic Target To Reduce Pancreatic Cancer

Authors: Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani.

Systematic Reviews in Pharmacy

Volume 12 · Issue 7 · Pages 2459–2464

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The cellular availability of NAD+ is essential for Sirtuin 1 (SIRT1), a class III histone deacetylase, catalytic activity which make it as a reliable metabolic sensor. For evidence, SIRT1 had a high expression in tissue with metabolic activity including muscle, brain, liver, pancreas, and adipose tissue. Previous reports have documented the crosstalk between SIRT1 and nuclear factor kappa-B (NF-κB) signaling in conditions such as lymphoma, leukemia, and myeloma. The purpose of present study is to find the relationships between SIRT1 and NF-κB activation on pancreatic cancer cells (Capan-2, AsPC-1, and BxPC-3). We found the activation of NF-κB was inhibited by use 1 µM SIRT1 aptamer by increased the activity of SIRT1 protein. Overall, our findings suggested that SIRT1 activation resulting in inhibition of pancreatic cancer cells growth and significantly repression of NF-κB proteins activation, this activation of SIRT1 by aptamer may be considered as a potential future therapy for cancer especially pancreatic cancer. How to Cite this Article Pubmed Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP. 2021; 12(3): 207-212. doi:10.31838/srp.2021.3.34 Web Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. http://www.sysrevpharm.org/?mno=51635 [Access: March 30, 2021]. doi:10.31838/srp.2021.3.34 AMA (American Medical Association) Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP. 2021; 12(3): 207-212. doi:10.31838/srp.2021.3.34 Vancouver/ICMJE Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP. (2021), [cited March 30, 2021]; 12(3): 207-212. doi:10.31838/srp.2021.3.34 Harvard Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani (2021) Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. SRP, 12 (3), 207-212. doi:10.31838/srp.2021.3.34 Turabian Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. 2021. Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. Systematic Reviews in Pharmacy, 12 (3), 207-212. doi:10.31838/srp.2021.3.34 Chicago Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. "Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer." Systematic Reviews in Pharmacy 12 (2021), 207-212. doi:10.31838/srp.2021.3.34 MLA (The Modern Language Association) Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani. "Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer." Systematic Reviews in Pharmacy 12.3 (2021), 207-212. Print. doi:10.31838/srp.2021.3.34 APA (American Psychological Association) Style Marwah Saad Joudah, Inam Sameh Arif, Basma Talib Al-Sudani (2021) Crosstalk Between Sirt1 Activators And Nf-Κb Axis As A Therapeutic Target To Reduce Pancreatic Cancer. Systematic Reviews in Pharmacy, 12 (3), 207-212. doi:10.31838/srp.2021.3.34

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Marwah Saad Joudah”
  • BylineArticles whose byline prints “Inam Sameh Arif”
  • BylineArticles whose byline prints “Basma Talib Al-Sudani.”